Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Bird

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Basic & Clinical Pharmacology & Toxicology|November 9, 2017
Evaluation of the Influence of Three Newly Developed Bispyridinium Anti-nicotinic Compounds (MB408, MB442, MB444) on the Efficacy of Antidotal Treatment of Nerve Agent Poisoning in MiceJiri Kassa, Christopher M Timperley, Mike Bird, et al.
Toxicology|July 15, 2018
Some benefit from non-oximes MB408, MB442 and MB444 in combination with the oximes HI-6 or obidoxime and atropine in antidoting sarin or cyclosarin poisoned miceJiri Kassa, Christopher M Timperley, Mike Bird, et al.
Toxicology Letters|December 13, 2019
Assessment of false transmitters as treatments for nerve agent poisoningCharlotte Whitmore, Christopher D Lindsay, Mike Bird, et al.
Toxicology Letters|February 5, 2020
3-Quinuclidinyl-α-methoxydiphenylacetate: A multi-targeted ligand with antimuscarinic and antinicotinic effects designed for the treatment of anticholinesterase poisoningChristopher M Timperley, Mike Bird, Samuel J Gore, et al.
Plos One|February 25, 2025
Structure-activity studies of bispyridinium antinicotinics to select candidates to treat soman intoxication as part of a combined therapySimon R Turner, Christopher M Timperley, Mike Bird, et al.
Toxicology Letters|January 22, 2021
Molecular determinants of binding of non-oxime bispyridinium nerve agent antidote compounds to the adult muscle nAChRMax Epstein, Karan Bali, Thomas J Piggot, et al.
Royal Society Open Science|June 12, 2015
Potency of irritation by benzylidenemalononitriles in humans correlates with TRPA1 ion channel activationChristopher D Lindsay, Christopher Green, Mike Bird, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Basic & Clinical Pharmacology & Toxicology|November 9, 2017
Evaluation of the Influence of Three Newly Developed Bispyridinium Anti-nicotinic Compounds (MB408, MB442, MB444) on the Efficacy of Antidotal Treatment of Nerve Agent Poisoning in MiceJiri Kassa, Christopher M Timperley, Mike Bird, et al.
Toxicology|July 15, 2018
Some benefit from non-oximes MB408, MB442 and MB444 in combination with the oximes HI-6 or obidoxime and atropine in antidoting sarin or cyclosarin poisoned miceJiri Kassa, Christopher M Timperley, Mike Bird, et al.
Toxicology Letters|December 13, 2019
Assessment of false transmitters as treatments for nerve agent poisoningCharlotte Whitmore, Christopher D Lindsay, Mike Bird, et al.
Toxicology Letters|February 5, 2020
3-Quinuclidinyl-α-methoxydiphenylacetate: A multi-targeted ligand with antimuscarinic and antinicotinic effects designed for the treatment of anticholinesterase poisoningChristopher M Timperley, Mike Bird, Samuel J Gore, et al.
Plos One|February 25, 2025
Structure-activity studies of bispyridinium antinicotinics to select candidates to treat soman intoxication as part of a combined therapySimon R Turner, Christopher M Timperley, Mike Bird, et al.
Toxicology Letters|January 22, 2021
Molecular determinants of binding of non-oxime bispyridinium nerve agent antidote compounds to the adult muscle nAChRMax Epstein, Karan Bali, Thomas J Piggot, et al.
Royal Society Open Science|June 12, 2015
Potency of irritation by benzylidenemalononitriles in humans correlates with TRPA1 ion channel activationChristopher D Lindsay, Christopher Green, Mike Bird, et al.
Pageof 2